Abstract
Raf kinases are important cancer drug targets. Paradoxically, many B-Raf inhibitors induce the activation of Raf kinases. Cryo-electron microscopy structural analysis of a phosphorylated B-Raf kinase domain dimer in complex with dimeric 14-3-3, at a resolution of ~3.9 angstroms, shows an asymmetric arrangement in which one kinase is in a canonical "active" conformation. The distal segment of the C-terminal tail of this kinase interacts with, and blocks, the active site of the cognate kinase in this asymmetric arrangement. Deletion of the C-terminal segment reduces Raf activity. The unexpected asymmetric quaternary architecture illustrates how the paradoxical activation of Raf by kinase inhibitors reflects an innate mechanism, with 14-3-3 facilitating inhibition of one kinase while maintaining activity of the other. Conformational modulation of these contacts may provide new opportunities for Raf inhibitor development.
🔬 Techniques
💻 Software
✨ Fluorophores
🧪 Sample Preparation
🔬 Cell Lines
🏭 Microscope Brands
🧪 Reagent Suppliers
💻 Software Details
💾 Data Repositories
🏛️ Research Organizations (ROR)
Affiliated research institutions:
📊 Figures
Figure 1.
Structure of the B-Raf:14-3-3 complex.
(A) Left, schematic diagram of the structure. Middle and right, two orthogonal views of the molecular surface of the cryo-EM model. The two B-Raf kinases in the dimer are shown in cyan and magenta, re...
Figure 2.
Interaction of the distal tail segment of B-Raf OUT with the active site of B-Raf IN .
(A) Orthogonal views of the cryo-EM structure of the B-Raf:14-3-3 complex. On the left, the C-tail of B-Raf OUT (magenta) is seen bound to 14-3-3 (gray) and the distal tail segment enters the active s...
Figure 3.
Mutational analysis of B-Raf.
(A) Left, schematic diagram of the cryo-EM structure, indicating the B-Raf variants that were analyzed. Right, schematic diagram of the B-Raf-u0394Nu0394DTS:14-3-3 complex, which lacks the N-terminal ...
Figure images are served from the NIH/NLM PubMed Central Open Access Subset or Europe PMC; copyright remains with the publishers and authors.
💬 Discussion
0 commentsNo comments yet. Be the first to start a discussion!
Leave a Comment